Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine A Pretreatment of Deceased Donor on Kidney Graft Function
NCT02907554Phase 4Completed
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Dec 2017
- Primary completion
- Apr 2022
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of cyclosporine in delayed graft function (DGF) (2 arms), sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Primary endpoint: Delayed Graft Function at 7 days. Started Dec 2017; status: completed.
02
Drugs
cyclosporine
03
Conditions
delayed graft function (DGF)
Beyond the preview
Go deeper on NCT02907554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02907554.